Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 mediated dysregulation in cell signaling events drives the severity of COVID-19. | Virus Res | 2023 | 36209917 | PubTator, text mining | PubMed |
| Ultrastructural analysis and three-dimensional reconstruction of cellular structures involved in SARS-CoV-2 spread. | Histochem Cell Biol | 2023 | 36175690 | PubTator, text mining | PubMed |
| Potential Cardiac Tamponade Development Secondary to SARS-CoV-2 Infection. | Curr Probl Cardiol | 2023 | 36155201 | PubTator, text mining | PubMed |
| Point-of-care electrochemical testing of biomarkers involved in inflammatory and inflammatory-associated medical conditions. | Anal Bioanal Chem | 2023 | 36102973 | PubTator, text mining | PubMed |
| Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, influenza A and B. | J Med Virol | 2023 | 36089764 | PubTator, text mining | PubMed |
| Identification of novel neutralizing determinants for protection against HCV. | Hepatology | 2023 | 36056620 | PubTator, text mining | PubMed |
| SARS CoV-2 detected in neonatal stool remote from maternal COVID-19 during pregnancy. | Pediatr Res | 2023 | 35986143 | PubTator, text mining | PubMed |
| Functional consequences of allotypic polymorphisms in human immunoglobulin G subclasses. | Immunogenetics | 2023 | 35904629 | PubTator, text mining | PubMed |
| Does pre-existing immunity determine the course of SARS-CoV-2 infection in health-care workers? Single-center experience. | Infection | 2023 | 35696057 | PubTator, text mining | PubMed |
| Evaluation of real-time NASBA assay for the detection of SARS-CoV-2 compared with real-time PCR. | Ir J Med Sci | 2023 | 35668337 | PubTator, text mining | PubMed |
| Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview. | Clin Exp Med | 2023 | 35362771 | PubTator, text mining | PubMed |
| The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing. | Mol Biotechnol | 2023 | 35091986 | PubTator, text mining | PubMed |
| SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches. | Appl Nanosci | 2023 | 34131555 | PubTator, text mining | PubMed |
| Diagnosis and treatment protocol for COVID-19 patients (Trial Version 9). | Health Care Sci | 2022 | 40478002 | PubTator, text mining | PubMed |
| Ubiquitin Modification of SARS-CoV-2 Membrane Protein Promotes Virion Assembly and Budding via Autophagy. | Autophagy Rep | 2022 | 40396052 | PubTator, text mining | PubMed |
| Sensitive methods for detection of SARS-CoV-2 RNA. | Methods Microbiol | 2022 | 38620918 | PubTator, text mining | PubMed |
| Recent and advanced nano-technological strategies for COVID-19 vaccine development. | Methods Microbiol | 2022 | 38620863 | PubTator, text mining | PubMed |
| Massive-scale genomic analysis reveals SARS-CoV-2 mutation characteristics and evolutionary trends. | mLife | 2022 | 37732331 | PubTator, text mining | PubMed |
| Recombination in sarbecovirus lineage and mutations/insertions in spike protein are linked to the emergence and adaptation of SARS-CoV-2. | Bioinformation | 2022 | 37693920 | PubTator, text mining | PubMed |
| The role of angiotensin-converting enzyme 2 (ACE2) genetic variations in COVID-19 infection: a literature review. | Egypt J Med Hum Genet | 2022 | 37521836 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=34